Literature DB >> 34298093

Iron deficiency exacerbates cisplatin- or rhabdomyolysis-induced acute kidney injury through promoting iron-catalyzed oxidative damage.

Shifeng Zhao1, Xueqiao Wang1, Xiaoqing Zheng1, Xiu Liang1, Zhigang Wang2, Juanlian Zhang1, Xudong Zhao3, Shougang Zhuang4, Qiuhui Pan5, Fenyong Sun6, Wenjun Shang7, Jonathan Barasch8, Andong Qiu9.   

Abstract

Iron deficiency is the most common micronutrient deficiency worldwide. While iron deficiency is known to suppress embryonic organogenesis, its effect on the adult organ in the context of clinically relevant damage has not been considered. Here we report that iron deficiency is a risk factor for nephrotoxic intrinsic acute kidney injury of the nephron (iAKI). Iron deficiency exacerbated cisplatin-induced iAKI by markedly increasing non-heme catalytic iron and Nox4 protein which together catalyze production of hydroxyl radicals followed by protein and DNA oxidation, apoptosis and ferroptosis. Crosstalk between non-heme catalytic iron/Nox4 and downstream oxidative damage generated a mutual amplification cycle that facilitated rapid progression of cisplatin-induced iAKI. Iron deficiency also exacerbated a second model of iAKI, rhabdomyolysis, via increasing catalytic heme-iron. Heme-iron induced lipid peroxidation and DNA oxidation by interacting with Nox4-independent mechanisms, promoting p53/p21 activity and cellular senescence. Our data suggests that correcting iron deficiency and/or targeting specific catalytic iron species are strategies to mitigate iAKI in a wide range of patients with diverse forms of kidney injury.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Catalytic iron; Cellular senescence; Ferroptosis; Heme; Hydroxyl radicals; Non-heme iron; Nox4

Mesh:

Substances:

Year:  2021        PMID: 34298093      PMCID: PMC9482792          DOI: 10.1016/j.freeradbiomed.2021.07.025

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   8.101


  114 in total

1.  The role of catalytic iron in acute kidney injury.

Authors:  Sudhir V Shah; Mohan M Rajapurkar; Radhakrishna Baliga
Journal:  Clin J Am Soc Nephrol       Date:  2011-10       Impact factor: 8.237

2.  Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury.

Authors:  Kiyoshi Mori; H Thomas Lee; Dana Rapoport; Ian R Drexler; Kirk Foster; Jun Yang; Kai M Schmidt-Ott; Xia Chen; Jau Yi Li; Stacey Weiss; Jaya Mishra; Faisal H Cheema; Glenn Markowitz; Takayoshi Suganami; Kazutomo Sawai; Masashi Mukoyama; Cheryl Kunis; Vivette D'Agati; Prasad Devarajan; Jonathan Barasch
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 3.  Iron Chelation as a Potential Therapeutic Strategy for AKI Prevention.

Authors:  Shreyak Sharma; David E Leaf
Journal:  J Am Soc Nephrol       Date:  2019-09-25       Impact factor: 10.121

Review 4.  Role of free radicals and catalytic metal ions in human disease: an overview.

Authors:  B Halliwell; J M Gutteridge
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

Review 5.  Free radical lipid peroxidation: mechanisms and analysis.

Authors:  Huiyong Yin; Libin Xu; Ned A Porter
Journal:  Chem Rev       Date:  2011-08-23       Impact factor: 60.622

6.  Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent.

Authors:  Tomonori Aoyama; Yong-Han Paik; Sumio Watanabe; Benoît Laleu; Francesca Gaggini; Laetitia Fioraso-Cartier; Sophie Molango; Freddy Heitz; Cédric Merlot; Cédric Szyndralewiez; Patrick Page; David A Brenner
Journal:  Hepatology       Date:  2012-12       Impact factor: 17.425

7.  Curcumin reduces renal damage associated with rhabdomyolysis by decreasing ferroptosis-mediated cell death.

Authors:  Melania Guerrero-Hue; Cristina García-Caballero; Alejandra Palomino-Antolín; Alfonso Rubio-Navarro; Cristina Vázquez-Carballo; Carmen Herencia; Diego Martín-Sanchez; Víctor Farré-Alins; Javier Egea; Pablo Cannata; Manuel Praga; Alberto Ortiz; Jesús Egido; Ana Belén Sanz; Juan Antonio Moreno
Journal:  FASEB J       Date:  2019-04-29       Impact factor: 5.191

Review 8.  4-Hydroxynonenal (HNE) modified proteins in metabolic diseases.

Authors:  José Pedro Castro; Tobias Jung; Tilman Grune; Werner Siems
Journal:  Free Radic Biol Med       Date:  2016-11-01       Impact factor: 7.376

9.  Hepcidin regulates intrarenal iron handling at the distal nephron.

Authors:  Boualem Moulouel; Dounia Houamel; Constance Delaby; Dimitri Tchernitchko; Sophie Vaulont; Philippe Letteron; Olivier Thibaudeau; Hervé Puy; Laurent Gouya; Carole Beaumont; Zoubida Karim
Journal:  Kidney Int       Date:  2013-04-24       Impact factor: 10.612

10.  Eukaryotic DNA polymerases require an iron-sulfur cluster for the formation of active complexes.

Authors:  Daili J A Netz; Carrie M Stith; Martin Stümpfig; Gabriele Köpf; Daniel Vogel; Heide M Genau; Joseph L Stodola; Roland Lill; Peter M J Burgers; Antonio J Pierik
Journal:  Nat Chem Biol       Date:  2011-11-27       Impact factor: 15.040

View more
  2 in total

1.  Farnesoid X receptor protects against cisplatin-induced acute kidney injury by regulating the transcription of ferroptosis-related genes.

Authors:  Dong-Hyun Kim; Hoon-In Choi; Jung Sun Park; Chang Seong Kim; Eun Hui Bae; Seong Kwon Ma; Soo Wan Kim
Journal:  Redox Biol       Date:  2022-06-23       Impact factor: 10.787

2.  Functional consequence of myeloid ferritin heavy chain on acute and chronic effects of rhabdomyolysis-induced kidney injury.

Authors:  Kayla R McCullough; Juheb Akhter; Mauhaun J Taheri; Amie Traylor; Anna A Zmijewska; Vivek Verma; Matthew C Hudson; Abhishek Sachdeva; Elise N Erman; Kyle H Moore; James F George; Subhashini Bolisetty
Journal:  Front Med (Lausanne)       Date:  2022-09-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.